• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

COVID-19

Posted inCOVID-19, Infections, Research

Eliminating Health Disparities Is Key to Ending Pandemic

by Mark Gubar December 29, 2021April 11, 2024

Misinformation, populism, and self-interest keep the COVID-19 that has enslaved the planet.

coronavirus
Posted inCOVID-19, Infections, Research

Three Billion Omicron Cases

by Timur Burkhanayev December 25, 2021April 11, 2024

Omicron, a new variant of the SARS-CoV-2 coronavirus, will infect nearly 40% of the world’s population.

Molnupiravir
Posted inCOVID-19, Infections, New Drugs, Regulatory

Molnupiravir Approved in the U.S.

by Tanya von Reuss December 23, 2021September 8, 2022

An oral antiviral drug by Merck & Co. has joined the armamentarium of the pharmacological fight against COVID-19.

Posted inCOVID-19, Infections, New Drugs, Regulatory

MIR 19: Surprising New Drug to Treat Coronavirus

by Mark Gubar December 23, 2021September 8, 2022

A Russian drug for COVID-19 has adopted a powerful RNA interference technology.

Paxlovid (nirmatrelvir + ritonavir).
Posted inCOVID-19, Infections, New Drugs, Regulatory

Paxlovid Approved in the U.S.

by Tanya von Reuss December 22, 2021September 8, 2022

Pfizer’s oral antiviral drug has entered the world’s main pharmaceutical market.

coronavirus
Posted inCOVID-19, Infections, Research

Omicron Variant: Latest Scientific News, Findings, Evidence, and Developments

by Nik Resovski and Timur Burkhanayev December 17, 2021April 11, 2024

Up-to-date scientific information about the new Omicron variant of SARS-CoV-2/COVID-19.

Posted inCOVID-19, Infections, Research

Universal Coronavirus Vaccine

by Alex Avisoni December 17, 2021April 11, 2024

The biotechnology industry must come up with a comprehensive defense against all coronaviruses.

Posts pagination

Newer posts 1 2 3 4 5 6 Older posts
BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×